Clinical trials
Phase 2 Cardiomyopathies trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Terminated | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Capricor Inc. | 2 |
| Alnylam Pharmaceuticals | 1 |
| Annetine Gelijns | 1 |
| Brigham and Women's Hospital | 1 |
| Celladon Corporation | 1 |
| Daiichi Sankyo | 1 |
| Deborah Ascheim | 1 |
| Eidos Therapeutics, a BridgeBio company | 1 |
| Heidi Moretti, MS, RD | 1 |
| Inova Health Care Services | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiomyopathies | 19 |
| Heart Failure | 9 |
| Cardiomyopathy, Hypertrophic | 3 |
| Alzheimer Disease | 2 |
| Amyloidosis | 2 |
| Cardiovascular Diseases | 2 |
| Heart Diseases | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Muscular Dystrophy, Duchenne | 2 |
| Ventricular Dysfunction | 2 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.